Plasma ctDNA TP53 Mutation and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis

Plasma ctDNA TP53 Mutation and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis

ObjectiveTo analyze the association between plasma circulating tumor DNA (ctDNA) TP53 mutation status and survival outcomes in breast cancer patients.MethodsPubMed, Embase, and the Cochrane Library were searched for relevant literature published between 2000 and 2025, examining the impact of plasma...

Full description

Saved in:

Bibliographic Details
Main Authors:	FAN Hao, LIANG Annan, ZOU Wei, GAO Guangxi, LIU Lijin, LIU Fei, ZHAO Lina, WU Zhihong
Format:	Article
Language:	zho
Published:	Editorial Office of Medical Journal of Peking Union Medical College Hospital 2025-07-01
Series:	Xiehe Yixue Zazhi
Subjects:	tp53 mutations breast cancer ctdna prognosis meta-analysis
Online Access:	https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2025-0434
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
by: Jin Li, et al.
Published: (2025-01-01)

Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer
by: Regina Mirgayazova, et al.
Published: (2024-12-01)

Concomitant ALK Fusion and TP53/EGFR Mutation Lead to Adverse Prognostic Outcome
by: Mingyuan Du, et al.
Published: (2024-12-01)

The relationship between TP53 Gene Mutation with treatment results in High-Grade Gliomas
by: Bac Thanh Nguyen, et al.
Published: (2024-05-01)

Assessing germline TP53 mutations in cancer patients: insights into Li-Fraumeni syndrome and genetic testing guidelines
by: Anastasiia Danishevich, et al.
Published: (2025-02-01)

LSD1 is a targetable vulnerability in gastric cancer harboring TP53 frameshift mutations
by: Suzeng Wang, et al.
Published: (2025-02-01)

CASES OF DIFFUSE LARGE B-CELL LYMPHOMA WITH FUNCTIONAL INTRON MUTATIONS IN THE TP53 GENE
by: E. N. Voropaeva, et al.
Published: (2020-03-01)

Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation
by: Gelan Zhu, et al.
Published: (2024-12-01)

Treatment outcomes for patients with newly diagnosed or relapsed/refractory TP53-mutated mantle cell lymphoma: a systematic review and meta-analysisResearch in context
by: Na Zhang, et al.
Published: (2025-07-01)

The Critical Role of TP53 in Developing Leukaemia in Human and Dogs, Review Article
by: ِAoula Al-Zebeeby, et al.
Published: (2025-06-01)

Differences in Gender and Overall Survival for Temperature-Sensitive TP53 Mutations in Gastroesophageal Cancer
by: Danial H. Shaikh, et al.
Published: (2024-11-01)

MGAT4A/Galectin9‐Driven N‐Glycosylation Aberration as a Promoting Mechanism for Poor Prognosis of Endometrial Cancer with TP53 Mutation
by: Zhen Zhu, et al.
Published: (2024-12-01)

Gene‐specific ctDNA dynamics predict tumour burden and survival outcomes in ESCC: A prospective cohort study
by: Rentong Gu, et al.
Published: (2025-08-01)

In-frame germline TP53 variant impairs p53 oligomerization and predisposes to cancer
by: Lucie Vanikova, et al.
Published: (2025-08-01)

Variation characteristics and clinical significance of TP53 in patients with myeloid neoplasms
by: Qiang Ma, et al.
Published: (2024-12-01)

Genetic Profiling in Chronic Lymphocytic Leukemia: The Role of TP53 Mutations and IGHV Status in Treatment Decision-Making – A Case Report
by: Kateryna Khurdepa, et al.
Published: (2024-10-01)

FKBP10 expression and TP53 mutation predict prognosis and chemotherapy response in triple-negative breast cancer
by: Yan Li, et al.
Published: (2025-07-01)

CircTP53/USP10/p53 signaling Axis as a Novel Regulator of Progression and Prognosis of Head and Neck Squamous Cell Carcinoma
by: Yin Wang, et al.
Published: (2025-08-01)

TP53 and KMT2D mutations associated with worse prognosis in peripheral T‐cell lymphomas
by: Lingling Wang, et al.
Published: (2024-07-01)

Effects of Tp53 Gene Mutations on the Survival of Non-Small Cell Lung Cancer (NSCLC); A Short Review
by: Zhang C, et al.
Published: (2025-01-01)

Machine learning-based ultrasound radiomics for predicting TP53 mutation status in hepatocellular carcinoma
by: Didi Bu, et al.
Published: (2025-04-01)

Identification and prognostic analysis of metabolic genes associated with TP53 mutation in multiple myeloma
by: Xiaoyan Tang, et al.
Published: (2024-12-01)

Insights into an uncommon case: axillary extramammary Paget’s disease and TP53 mutation
by: Julia Zawistowska, et al.
Published: (2025-01-01)

Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutations: a prospective cohort study
by: Jixian Li, et al.
Published: (2025-07-01)

A Case of Lung Squamous Cell Carcinoma Harboring TP53 Mutation and PLPP5‐FGFR1 Fusion Gene
by: Meng Xiao‐ru, et al.
Published: (2025-04-01)

TP53-mutated MDS and AML: immune dysregulation, tumor microenvironment, and emerging therapeutic strategies
by: Marwah M. Albakri, et al.
Published: (2025-08-01)

<i>TP53</i> Mutations in Chagasic Megaesophagus
by: Aparecida Perpetuo Fedossi Silveira, et al.
Published: (2025-03-01)

Restoration of TP53 strategy via specific nanoparticles for ovarian cancer therapy
by: Menglei Zhang, et al.
Published: (2025-05-01)

Role of TP53 Mutations and EGFR Amplification in Risk Stratification of Early‐Stage EGFR‐Mutated Non‐Small Cell Lung Cancer With Immunohistochemistry as a Surrogate Marker
by: Meejeong Kim, et al.
Published: (2025-04-01)

Generation of TP53 knock out induced pluripotent stem cell using CRISPR/Cas9
by: Haonan Zhou, et al.
Published: (2025-06-01)

TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas
by: Yingao Zhang, et al.
Published: (2025-08-01)

Genomic Differences and Distinct TP53 Mutation Site‐Linked Chemosensitivity in Early‐ and Late‐Onset Gastric Cancer
by: Tomohiro Kamio, et al.
Published: (2025-04-01)

Dynamic predictive power of TP53 signatures in breast cancer prognosis: Pre- and post-neoadjuvant chemotherapy insights
by: Keiju Sasaki, et al.
Published: (2025-06-01)

TP53 Mutations R175H and R249S Are Rare in Indian Head and Neck Cancer Patients
by: Arjita Ghosh, et al.
Published: (2024-02-01)

Functional validation of somatic variability in TP53 and KRAS for prediction of platinum sensitivity and prognosis in epithelial ovarian carcinoma patients
by: Al Obeed Allah Mohammad, et al.
Published: (2025-12-01)

The relationship between TP53 and clinicopathological characteristics and their impact on the survival prognosis of patients with stage Ⅱ/Ⅲ colorectal cancer
by: Huang Lifeng, et al.
Published: (2023-06-01)

Iron overload mediates cytarabine resistance in AML by inhibiting the TP53 signaling pathway
by: Jia Yan, et al.
Published: (2025-02-01)

Exploring the role of splicing in TP53 variant pathogenicity through predictions and minigene assays
by: Cristina Fortuno, et al.
Published: (2025-01-01)

Circulating Tumor DNA (ctDNA) in Kidney Cancer: A Narrative Review
by: Wesley Yip, et al.
Published: (2023-07-01)

POLYMORPHISM OF THE TP53 GENE IN PATIENTS WITH GASTRIC CANCER IN PROSPECTIVE AND CLINICAL CASE-CONTROL STUDIES
by: A. V. Belkovets, et al.
Published: (2018-07-01)